Effectiveness of neurofeedback versus medication for attention-deficit/hyperactivity disorder
| Autor: | Umaporn Udomsubpayakul, Khemika Khemakanok Sudnawa, Vilawan Chirdkiatgumchai, Nichara Ruangdaraganon, Chaiyos Khongkhatithum, Suwicha Jirayucharoensak, Pasin Israsena |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
Pediatrics medicine.medical_specialty Neuropsychological Tests behavioral disciplines and activities law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial Rating scale law mental disorders Medicine Attention deficit hyperactivity disorder Humans 0501 psychology and cognitive sciences Adhd symptoms Adverse effect Child business.industry Methylphenidate 05 social sciences Neurofeedback medicine.disease Alternative treatment Treatment Outcome Attention Deficit Disorder with Hyperactivity Pediatrics Perinatology and Child Health Central Nervous System Stimulants Female business 030217 neurology & neurosurgery 050104 developmental & child psychology medicine.drug |
| Zdroj: | Pediatrics international : official journal of the Japan Pediatric Society. 60(9) |
| ISSN: | 1442-200X |
| Popis: | Background Neurofeedback (NF) is an operant conditioning procedure that trains participants to self-regulate brain activity. NF is a promising treatment for attention-deficit/hyperactivity disorder (ADHD), but there have been only a few randomized controlled trials comparing the effectiveness of NF with medication with various NF protocols. The aim of this study was therefore to evaluate the effectiveness of unipolar electrode NF using theta/beta protocol compared with methylphenidate (MPH) for ADHD. Methods Children with newly diagnosed ADHD were randomly organized into NF and MPH groups. The NF group received 30 sessions of NF. Children in the MPH group were prescribed MPH for 12 weeks. Vanderbilt ADHD rating scales were completed by parents and teachers to evaluate ADHD symptoms before and after treatment. Student's t-test and Cohen's d were used to compare symptoms between groups and evaluate the effect size (ES) of each treatment, respectively. Results Forty children participated in the study. No differences in ADHD baseline symptoms were found between groups. After treatment, teachers reported significantly lower ADHD symptoms in the MPH group (P = 0.01), but there were no differences between groups on parent report (P = 0.55). MPH had a large ES (Cohen's d, 1.30-1.69), while NF had a moderate ES (Cohen's d, 0.49-0.68) for treatment of ADHD symptoms. Conclusion Neurofeedback is a promising alternative treatment for ADHD in children who do not respond to or experience significant adverse effects from ADHD medication. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text